GOSSAMER BIO INC's ticker is GOSS and the CUSIP is 38341P102. A total of 83 filers reported holding GOSSAMER BIO INC in Q3 2019. The put-call ratio across all filers is 0.65 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $38,317,000 | +2208.3% | 3,198,382 | +1512.2% | 2.68% | +2025.4% |
Q2 2022 | $1,660,000 | -3.6% | 198,382 | 0.0% | 0.13% | -4.5% |
Q1 2022 | $1,722,000 | -23.3% | 198,382 | 0.0% | 0.13% | -0.8% |
Q4 2021 | $2,244,000 | -10.0% | 198,382 | 0.0% | 0.13% | +31.7% |
Q3 2021 | $2,494,000 | +54.8% | 198,382 | 0.0% | 0.10% | +83.6% |
Q2 2021 | $1,611,000 | -79.5% | 198,382 | -76.6% | 0.06% | -68.6% |
Q1 2021 | $7,848,000 | -4.3% | 848,382 | 0.0% | 0.18% | -10.3% |
Q4 2020 | $8,204,000 | +166.2% | 848,382 | +241.6% | 0.20% | +63.9% |
Q3 2020 | $3,082,000 | -32.1% | 248,382 | -28.9% | 0.12% | -31.2% |
Q2 2020 | $4,541,000 | +125.5% | 349,325 | +76.1% | 0.17% | +84.0% |
Q1 2020 | $2,014,000 | -57.0% | 198,382 | -33.9% | 0.09% | -49.7% |
Q4 2019 | $4,689,000 | -54.8% | 300,000 | -51.5% | 0.19% | -70.4% |
Q3 2019 | $10,378,000 | -27.2% | 618,129 | -3.9% | 0.63% | -22.8% |
Q2 2019 | $14,265,000 | +0.8% | 643,129 | -1.5% | 0.82% | -14.4% |
Q1 2019 | $14,153,000 | – | 653,129 | – | 0.96% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Omega Fund Management, LLC | 3,320,608 | $41,209,000 | 11.15% |
Boxer Capital, LLC | 2,562,358 | $31,799,000 | 1.10% |
Integral Health Asset Management, LLC | 200,000 | $2,482,000 | 0.76% |
Palo Alto Investors LP | 1,077,200 | $13,368,000 | 0.73% |
Artal Group S.A. | 2,358,968 | $29,275,000 | 0.71% |
HHLR ADVISORS, LTD. | 7,420,974 | $92,094,000 | 0.70% |
MASTERS CAPITAL MANAGEMENT LLC | 700,000 | $8,687,000 | 0.58% |
Ikarian Capital, LLC | 582,494 | $7,229,000 | 0.52% |
CLOUGH CAPITAL PARTNERS L P | 459,834 | $5,707,000 | 0.41% |
Alyeska Investment Group, L.P. | 1,173,301 | $14,561,000 | 0.22% |